Exact Mass: 673.2958928
Exact Mass Matches: 673.2958928
Found 53 metabolites which its exact mass value is equals to given mass value 673.2958928,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ustiloxin A
C28H43N5O12S (673.2628798000001)
Ustiloxin A is found in cereals and cereal products. Ustiloxin A is isolated from the false smut balls caused by Ustilaginoidea virens on rice. Isolated from the false smut balls caused by Ustilaginoidea virens on rice. Ustiloxin A is found in cereals and cereal products.
F1alpha
triferuloyl spermidine
Triferuloyl spermidine belongs to hydroxycinnamic acids and derivatives class of compounds. Those are compounds containing an cinnamic acid (or a derivative thereof) where the benzene ring is hydroxylated. Triferuloyl spermidine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Triferuloyl spermidine can be found in a number of food items such as japanese chestnut, jicama, lovage, and hickory nut, which makes triferuloyl spermidine a potential biomarker for the consumption of these food products.
Pro Trp Trp Trp
Trp Pro Trp Trp
Trp Trp Pro Trp
Trp Trp Trp Pro
Ustiloxin A
C28H43N5O12S (673.2628798000001)
SNAG-delta5-CA
C32H51NO12S (673.3131806000001)
5-DMT-Bz-rA
C38H35N5O7 (673.2536359999999)
5'-O-DMT-Bz-rA is an intermediate for cyclic di-nucleotide compounds?synthesis[1].
Methylprednisolone suleptanate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
Dihydro-alpha-ergocryptine mesylate
C33H47N5O8S (673.3145182000001)
N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Dihydro-beta-ergocryptine methanesulfonate
C33H47N5O8S (673.3145182000001)
N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-thiophenesulfonamide
N-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-thiophenesulfonamide
[(1S,2S,3R,4R,5S,6S,7S,8R,13R,14R,16S,17S,18R)-8,14-diacetyloxy-5,7-dihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-methyl-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] benzoate
Dihydro-beta-ergocryptine mesylate
C32H43N5O5. CH4SO3 (673.3145182000001)
2,3-dihydroxy-n-(3-{n-[3-({hydroxy[2-(2-hydroxyphenyl)-5-methyl-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)propyl]-1-[2-(2-hydroxyphenyl)-5-methyl-4,5-dihydro-1,3-oxazol-4-yl]formamido}propyl)benzenecarboximidic acid
(2s)-1-[(2s)-2-{[(2s)-1-hydroxy-2-[(2-methylbut-3-en-2-yl)amino]-3-phenylpropylidene]amino}-3-phenylpropanoyl]-n-[(1r)-1-[4-(methoxycarbonyl)-1,3-thiazol-2-yl]-2-methylpropyl]pyrrolidine-2-carboximidic acid
n-{3-[(2s,5s,17s)-3,6,9,12,15,18-hexahydroxy-5-[3-(n-hydroxyacetamido)propyl]-17-[3-(n-hydroxyformamido)propyl]-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]propyl}-n-hydroxyacetamide
2,3-dihydroxy-n-{3-[n-(3-{[hydroxy({5-methyl-2-[(1z)-6-oxocyclohexa-2,4-dien-1-ylidene]-1,3-oxazolidin-4-yl})methylidene]amino}propyl)-1-[(4s,5r)-5-methyl-2-[(1z)-6-oxocyclohexa-2,4-dien-1-ylidene]-1,3-oxazolidin-4-yl]formamido]propyl}benzenecarboximidic acid
(8s,10s)-8-acetyl-10-{[(2r,4s,5s,6s)-4-amino-5-{3-hydroxy-1-[(1-hydroxypropan-2-yl)oxy]butoxy}-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
(2s)-1-[(2s)-2-{[(2s)-1-hydroxy-2-[(2-methylbut-3-en-2-yl)amino]-3-phenylpropylidene]amino}-3-phenylpropanoyl]-n-[(1r)-1-[5-(methoxycarbonyl)-1,3-thiazol-2-yl]-2-methylpropyl]pyrrolidine-2-carboximidic acid
2-amino-5-[4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-7-isopropyl-3-methyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid
C28H43N5O12S (673.2628798000001)
(3r,6r,9r,15s,18s)-18-benzyl-5,8,11,14,17-pentahydroxy-3,9-bis[(4-hydroxyphenyl)methyl]-6,15-dimethyl-1-oxa-4,7,10,13,16-pentaazacyclooctadeca-4,7,10,13,16-pentaen-2-one
(2s,4s)-2-amino-5-[(3r,4s,7s,10s,11r)-4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-7-isopropyl-3-methyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid
C28H43N5O12S (673.2628798000001)
(2s,4s)-2-amino-5-[(s)-(3r,4s,7s,10s,11r)-4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-7-isopropyl-3-methyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid
C28H43N5O12S (673.2628798000001)
(1r,3r,4s,6r,8r,9s,10s,12r,13r,14s,15s)-1,10,12,14-tetrakis(acetyloxy)-9-hydroxy-3,7,7,15-tetramethyl-11-methylidene-2-oxo-5-oxatricyclo[11.3.0.0⁴,⁶]hexadecan-8-yl pyridine-3-carboxylate
(7r,8r,10s)-10-{[(2s,4s,5r,6s)-5-{[(2r,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,7,8,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
(2s,4s)-2-amino-5-[(r)-(3r,4s,7s,10s,11r)-4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-7-isopropyl-3-methyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid
C28H43N5O12S (673.2628798000001)